Population record
Saudi Arabia · 9 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| population | Saudi Arabia | “SDHB-associated paraganglioma in Saudi Arabia: High metastatic risk linked to a likely founder mutation. OBJECTIVE: To characterize the phenotype, genotype, and outcome of SDHB-associated PPGLs in Saudi Arabia. METHODS: We retrospectively reviewed a cohort of 37 patients with SDHB-associated PPGL.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Evaluation of the vitamin D response index in a Saudi cohort. In contrast, when we used in a subset of 37 study participants whole blood expression changes of seven well-known vitamin D target genes one and thirty days after supplementation as alternative biomarkers, only 9 persons (24 %) were identified as low responders. In conclusion, in Saudi Arabia the rate of low vitamin D responders is equal or even higher than that in Finland. Therefore, similar to Nordic countries also in Saudi Arabia appropriate vitamin D3 supplementation is essential, in order to fulfill the needs of low responders.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Interleukin-6 gene polymorphism in Saudi population with recurrent aphthous stomatitis. METHODOLOGY: A total of 37 RAS patients and 18 healthy controls were included in the study.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “RESULTS: A total of 37 patients were included in this analysis, with a mean age of 13.4±3.9 years and a mean duration of illness of 2.1±2.4 years. CONCLUSIONS: Metabolic bone disease is very common in this cohort of Saudi Arabian children and adolescents with ulcerative colitis and its occurrence appears to increase in female patients who suffer from extraintestinal manifestations.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “A multicenter study including 37 patients diagnosed with acute methanol intoxication and referred to three major poison control centers in Saudi Arabia during the past 3 years (January 1, 2018-January 1, 2021) was conducted.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia. In this study, we profiled a targeted panel of cancer-related genes in 37 Saudi Arabian patients with pLGGs to identify genetic abnormalities that can inform prognostic and therapeutic decision-making.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Clinical, Biochemical, and Molecular Features in 37 Saudi Patients with Very Long Chain Acyl CoA Dehydrogenase Deficiency. The aim of this study was to analyze the clinical, biochemical, and molecular features of VLCAD deficiency in Saudi Arabia, including the treatment and outcome. METHODS: We carried out a retrospective chart review analysis of 37 VLCAD deficiency patients from two tertiary centers in Saudi Arabia, over a 14-year period (2002-2016). Despite early diagnosis and treatment, the outcome of VLCAD deficiency in this Saudi Arabian population remains poor.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “The most common mutation was the 3.7 single gene deletion and was found in 37 patients (n=37/95, 39%). Others common mutations were the 20.5 kb double gene deletion (n=20 patients, 21%), MED double gene deletion (n=17 patients, 17.9%), α2 IVS1 (n=10 patients, 10.5%), α2 cd142 Hb Koya Dora (n=6 patients, 6.3%), α2 polyA1 (Saudi type) (n=6 patients, 6.3%), 4.2 single gene deletion (n=4 patients, 4.2%), α1 cd14 (n=2 patients, 2.1%), and -FIL mutation (n=2 patients 2.1%), respectively.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Indirect immunohistochemistry for KS (mAbs 3D12/H7 and 5-D-4) was performed on 44 corneas of 37 patients with MCD including two recurrences. MCD immunophenotype I A can not only be found in Saudi Arabia, but is as common as immunophenotype I in German patients.” | 0.95 | saudi_context_rules_v1 |